AI Could Revolutionize Cancer Care By Detecting High-Risk Tumors More Accurately

A recent study conducted by the Royal Marsden NHS Foundation Trust and the Institute of Cancer Research (ICR) highlights AI's capabilities in assessing cancer aggressiveness.

Related Keywords

United States ,Starpax Biopharma ,Wellcome ,Care Research ,Institute Of Cancer Research ,National Institute For Health ,Bone Sarcoma Group ,Royal Marsden Cancer Charity ,Royal Marsden ,Cancer Research ,Lancet Oncology ,Kevino Leary Backed ,National Institute ,Wellcome Trust ,Bone Sarcoma ,